tiprankstipranks
Trending News
More News >
MDB Capital Holdings, LLC Class A (MDBH)
NASDAQ:MDBH
US Market

MDB Capital Holdings, LLC Class A (MDBH) AI Stock Analysis

Compare
14 Followers

Top Page

MDBH

MDB Capital Holdings, LLC Class A

(NASDAQ:MDBH)

Select Model
Select Model
Select Model
Neutral 55 (OpenAI - 5.2)
Rating:55Neutral
Price Target:
$3.50
▼(-0.57% Downside)
Action:ReiteratedDate:02/03/26
Overall score reflects pressured operating/cash-flow quality despite a strong, low-leverage balance sheet. Technicals also point to a weak downtrend. Offsetting these, the stock appears inexpensive on P/E, and earnings-call commentary outlines an ambitious scaling plan, though execution risks (burn and delays) remain meaningful.
Positive Factors
Low leverage / strong balance sheet
Very low debt and a sizable equity base provide durable financial flexibility to fund deal activity, absorb operating shortfalls, and postpone dilutive financing. This reduces refinancing risk and supports the firm’s ability to execute multi-year launch plans even if cashflow remains weak.
Proven IPO track record and pipeline
A long track record of successful public launches and a late-stage pipeline (4–5 companies) underpin a repeatable fee and equity-value generation model. Persistent origination capability supports sustainable advisory and underwriting revenues as the firm scales launches to 3–5 per year.
Strengthened governance and microcap expertise
Adding a seasoned, independent audit committee member with microcap investing and financial expertise should improve oversight, deal sourcing and financial controls. Better governance can reduce execution risk, enhance credibility with issuers/investors, and support fundraising efforts.
Negative Factors
Weak cash generation
Persistent negative operating and free cash flow means reported earnings are not converting to cash, pressuring liquidity for ongoing launches. Over months this forces reliance on external financing or asset sales, raising execution risk and threatening sustainable funding of growth initiatives.
Unprofitable core operations
Negative gross profit and operating losses indicate core deal economics and cost structure don't scale yet. With net income driven by non-operating items, underlying margin sustainability is weak, making future profitability conditional on material operational improvements or structural business changes.
High operating burn and project delays
Meaningful operating expense burn and delayed monetization of key assets extend the timeline to generate fee and equity returns. Over several months this increases funding needs, heightens execution risk for the scaling plan, and could dilute returns if additional capital is required.

MDB Capital Holdings, LLC Class A (MDBH) vs. SPDR S&P 500 ETF (SPY)

MDB Capital Holdings, LLC Class A Business Overview & Revenue Model

Company DescriptionMDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business. The company was founded in 1997 and is based in Addison, Texas.
How the Company Makes MoneyMDB Capital Holdings generates revenue through several key streams. Primarily, it earns fees from its investment management services, which include asset management fees based on the performance of the funds it manages. Additionally, the company may receive success fees or commissions from advisory services provided to startups and established firms within its focus sectors. MDBH also potentially benefits from equity stakes in the companies it advises or invests in, allowing it to profit from successful exits or public offerings. Partnerships with technology firms and biotech companies further enhance its revenue potential by creating opportunities for co-investment and joint ventures.

MDB Capital Holdings, LLC Class A Earnings Call Summary

Earnings Call Date:Nov 20, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Apr 22, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted MDB Capital Holdings' successful track record in launching IPOs and scaling operations for future growth. However, significant challenges remain, including a declining stock price and a tough microcap market. Despite positive developments in their pipeline and upcoming launches, the operational expenses and delays in key projects temper the optimism.
Q3-2025 Updates
Positive Updates
Successful IPO Track Record
MDB Capital Holdings has launched numerous successful IPOs over 28 years, with 100% trading at 2x the IPO price at some point post-IPO.
Deep Pipeline of Opportunities
The company has a strong pipeline with 4 to 5 companies in late-stage negotiations, aiming for 3 to 5 launches next year.
eXoZymes and HeartBeam Developments
eXoZymes is expected to revolutionize pharmaceutical development, and HeartBeam is on the verge of FDA approval for a groundbreaking 12-lead ECG device.
Scaling Operations
MDB Capital Holdings aims to scale operations to launch 3 to 5 companies per year, supported by a proven operational framework.
Potential Spinout of PatentVest
Plans to spin out PatentVest, potentially the first public law firm in the U.S., focused on patent law.
Negative Updates
Stock Price Decline
MDB Capital Holdings' stock has declined significantly, trading at a discount despite existing equity positions exceeding market value.
Microcap Market Challenges
The microcap market has been challenging, with concerns about MDB's ability to pick successful ventures.
Operational Expenses
Operating expenses have yet to be fully offset by financings, with $5.9 million used in the first three quarters.
Delays in eXoZymes and Paulex Bio
Delays in monetizing eXoZymes and bringing Paulex Bio to market have been noted, impacting anticipated timelines.
Company Guidance
During the MDB Capital Holdings Third Quarter 2025 Update Conference Call, the company provided guidance emphasizing their strategy to scale operations by increasing the number of annual public venture launches from one every 18 months to three to five per year. CEO Chris Marlett highlighted MDB's plan to cover its $10 million operating expenses through financing activities while maintaining significant equity positions in launched companies, such as Paulex Bio and Buda Juice, to offer substantial shareholder value. Marlett expressed optimism about the potential resurgence of the microcap market, noting the scarcity of small public companies and the demand for public market liquidity. Additionally, MDB remains committed to delivering asymmetric returns by curating category-leading companies and positioning them for success in public markets. The company also aims to enhance investor relations efforts to better communicate the value of its portfolio and plans to leverage its unique public venture platform to capitalize on upcoming market opportunities.

MDB Capital Holdings, LLC Class A Financial Statement Overview

Summary
Mixed fundamentals: strong, low-leverage balance sheet and positive net income, but core operations look weak with persistently negative gross profit, negative EBIT, and negative operating/free cash flow that worsened versus 2024.
Income Statement
46
Neutral
Revenue accelerated sharply in TTM (Trailing-Twelve-Months) (up ~41%), but profitability quality is mixed. Gross profit remains deeply negative in both TTM and 2024, pointing to a cost structure that is not scaling well. Net income is positive in TTM and 2024 after losses in 2021–2023, but large operating losses (negative EBIT) suggest the bottom-line profitability is being driven by non-operating items rather than core operations, which reduces confidence in earnings sustainability.
Balance Sheet
78
Positive
The balance sheet is a clear strength: leverage is very low (debt-to-equity near zero in TTM and ~1% in 2024) with a sizable equity base relative to total assets. Return on equity is solidly positive in TTM and 2024 after being negative in 2021–2023, indicating improved shareholder returns. Key watch-out: equity declined from 2024 to TTM, so the direction of capital/base stability bears monitoring even with low debt.
Cash Flow
34
Negative
Cash generation is weak and volatile. Operating cash flow and free cash flow are negative in TTM and 2024 (and were also negative through most of 2021–2023), despite positive net income—suggesting earnings are not translating into cash. Free cash flow also deteriorated in TTM versus 2024, which raises funding and sustainability questions unless operating cash flow improves meaningfully.
BreakdownTTMMar 2025Mar 2024Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue4.31M2.22M4.23M1.12M0.000.00
Gross Profit-8.72M-17.84M-4.39M-1.71M-1.97M-1.78M
EBITDA19.13M12.33M-9.76M-5.97M-5.67M-4.21M
Net Income11.43M11.69M-6.97M-5.31M-15.10M-722.18K
Balance Sheet
Total Assets61.51M71.98M42.99M25.70M8.25M27.94M
Cash, Cash Equivalents and Short-Term Investments15.93M20.44M6.11M4.95M6.23M12.48M
Total Debt635.42K711.50K2.42M1.42M720.63K251.34K
Total Liabilities1.88M1.90M5.67M2.59M1.49M3.33M
Stockholders Equity59.74M70.16M37.31M22.64M6.24M24.67M
Cash Flow
Free Cash Flow-4.13M-8.49M-7.60M-6.77M-6.26M9.44M
Operating Cash Flow-4.75M-9.04M-7.16M-6.57M-5.83M9.50M
Investing Cash Flow1.83M22.89M-8.20M-16.38M-423.39K-62.13K
Financing Cash Flow587.37K69.30K17.76M21.68M0.00250.96K

MDB Capital Holdings, LLC Class A Technical Analysis

Technical Analysis Sentiment
Negative
Last Price3.52
Price Trends
50DMA
3.31
Negative
100DMA
3.46
Negative
200DMA
3.71
Negative
Market Momentum
MACD
-0.07
Negative
RSI
46.37
Neutral
STOCH
31.39
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MDBH, the sentiment is Negative. The current price of 3.52 is above the 20-day moving average (MA) of 3.14, above the 50-day MA of 3.31, and below the 200-day MA of 3.71, indicating a bearish trend. The MACD of -0.07 indicates Negative momentum. The RSI at 46.37 is Neutral, neither overbought nor oversold. The STOCH value of 31.39 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MDBH.

MDB Capital Holdings, LLC Class A Risk Analysis

MDB Capital Holdings, LLC Class A disclosed 79 risk factors in its most recent earnings report. MDB Capital Holdings, LLC Class A reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

MDB Capital Holdings, LLC Class A Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
$76.81M10.448.43%8.47%-32.22%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
63
Neutral
$29.50M6.099.56%6.45%214.07%-40.88%
61
Neutral
$49.15M0.55-29.28%
55
Neutral
$31.76M2.7225.75%121.21%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MDBH
MDB Capital Holdings, LLC Class A
3.13
-3.73
-54.33%
COHN
Cohen & Company
14.49
6.58
83.07%
SIEB
Siebert Financial
1.90
-0.55
-22.45%
DOMH
Dominari Holdings
3.03
-2.72
-47.30%
TOP
Zhong Yang Financial Group Ltd.
1.01
-0.22
-17.89%
GSIW
Garden Stage Ltd.
0.11
-0.38
-77.55%

MDB Capital Holdings, LLC Class A Corporate Events

Executive/Board Changes
MDB Capital Holdings appoints new independent audit director
Positive
Feb 2, 2026

On February 1, 2026, MDB Capital Holdings, LLC appointed 73-year-old investment veteran Jeb Terry Sr. as an independent director and member of its audit committee, with his initial term running until the company’s next annual meeting of stockholders. Terry, who has over two decades of experience investing in microcap medical and biotechnology companies and a background spanning venture capital, private equity, banking, and hedge fund management, was selected for his extensive work as a registered investment adviser and his ability to source small-cap opportunities, and has been deemed both an independent director under Nasdaq standards and a financial expert. As part of his compensation, he will receive a $50,000 annual cash payment and options for up to 100,000 Class A shares that vest over time, subject to continued service and the company’s clawback policy. Also effective February 1, 2026, long-serving director Susanne Meline resigned from the board to pursue retirement, a change that marks both a generational transition in board composition and a bolstering of financial and microcap investment expertise at the board and audit committee level for MDB Capital’s stakeholders.

The most recent analyst rating on (MDBH) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on MDB Capital Holdings, LLC Class A stock, see the MDBH Stock Forecast page.

Shareholder Meetings
MDB Capital Holds Successful Annual Stockholders Meeting
Positive
Dec 4, 2025

On December 2, 2025, MDB Capital Holdings, LLC held its Annual Meeting of Stockholders, where shareholders elected seven directors to serve until the 2026 meeting and ratified RBSM LLP as the independent accounting firm for the fiscal year ending December 31, 2025. The meeting saw a significant turnout, with 84.90% of eligible votes represented, and all proposals passed without broker non-votes, indicating strong shareholder support for the company’s governance and financial oversight decisions.

The most recent analyst rating on (MDBH) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on MDB Capital Holdings, LLC Class A stock, see the MDBH Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 03, 2026